Bevacizumab - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
BEVACIPTIN bevacizumab 100 mg/4 mL concentrated solution for infusion vial AUST R: 347292Active ingredients:
Bevacizumab
Dosage form:
Injection, concentrated
Sponsor:
Cipla Australia Pty Ltd
Phone:
0396964413
|
From
02 Aug 2024
to
31 Jan 2025
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Commercial Changes / Commercial viability
Management action:
The sponsor is working to expedite the next shipment. Alternative generic products are available.
|